This education session will explore the latest trends and information about biosimilars in pharmacy. This wide-ranging discussion will define what biosimilars are, their benefits, how they differ from biologics, biosimilar therapy for patients, and strategies for managing product substitution. We will also examine new regulations surrounding the use of biosimilars in practice and provide resources that pharmacists can use to stay up to date on new developments.

Learning objectives:

1. Identify a definition of biosimilars and identify their similarities and differences to generics.

2. Explain how to plan, develop, and implement a biosimilars program.

3. Demonstrate strategies to get buy-in from clinicians on the use of biosimilars.

4. Evaluate current organization processes and identify opportunities for biosimilar utilization.